Neurology: Neuroimmunology & Neuroinflammation Manuscript Classifications

Specifications for Manuscript Categories

(See expanded descriptions following table)

Manuscript Type	Word Count (excluding abstracts, tables, figure legends, references)	Abstract	References	Total Figures/Tables
Scientific Contributions
Articles	≤ 3500 + supplemental material online (additional references and ≤ 3 figures/tables)	≤ 250	≤ 40	≤ 5
Articles (Smaller scope studies)	≤ 1250	≤ 250	≤ 10	≤ 3
Clinical/Scientific Notes	≤ 750	None	≤ 7	≤ 1
Special Categories
Views & Reviews	≤ 3500	≤ 250	≤ 60	≤ 6
Letters	≤ 200	≤ None	≤ 5	≤ N/A

Articles

Articles are full-length reports of original research. These include large-scale pivotal trials of new therapies (randomized clinical trials). According to ClinicalTrials.gov, clinical trials "are generally considered to be biomedical or health-related research studies in human beings that follow a pre-defined protocol. ClinicalTrials.gov includes both interventional and observational types of studies. Interventional studies are those in which the research subjects are assigned by the investigator to a treatment or other intervention, and their outcomes are measured. Observational studies are those in which individuals are observed and their outcomes are measured by the investigators.

Specifications:

• Structured abstract containing a 1-sentence Objective, Methods, Results, and Conclusions (maximum 250 words).
• Maximum of 3500 words (not including abstract, figure legends, table legends, references)
• Limit of 40 references.
• Limit of 5 figures and tables total. Additional figures or tables can be published online. Tables should not repeat data in the text.
• (Alternatively, authors can limit to 3000 words and 6 figures or less are allowed).

Articles (Smaller Scope Studies)

Neurology: Neuroimmunology & Neuroinflammation will consider smaller (e.g., 10-50 participants), uncontrolled, nonrandomized, or unblinded clinical trials as Articles. This category includes preliminary observations or pilot studies or presentation of one or a few informative cases. These manuscripts should be uploaded under "Article" in the Neurology: Neuroimmunology & Neuroinflammation tracking system. Editors will make final decisions regarding length of these articles.

Specifications:

• Maximum of 1250 words (not including abstract, figure legends, table legends, references)
• Structured abstract, maximum of 250 words
• No more than 10 references
• Maximum of 3 tables and/or figures

Clinical/Scientific Notes

Clinical/Scientific Notes are abbreviated reports on cases or preliminary studies.

Specifications:

• Maximum of 750 words
• No abstract (the title serves as abstract)
• No more than 1 table or figure
• No more than 7 references

Special Categories

Views & Reviews

Views & Reviews are either a review or an opinion statement that provides a summary of the most important recent information on a topic. If the Review summarizes recommendations for practice, use the word "Recommendations" in the title rather than "Guidelines." (Guidelines published in the Journal are created by an established process by the American Academy of Neurology.)

Specifications:

• Maximum of 3500 words, excluding references
• Abstract (structured optional), maximum 250 words
• Maximum of 60 references (additional may appear as supplemental data)
• No more than 6 tables and/or figures

Letters

The goal of this section is to encourage concise, rapid debate among authors and readers of Neurology: Neuroimmunology & Neuroinflammation Letters are restricted to comments about studies published in Neurology: Neuroimmunology & Neuroinflammation within the past two issues, with the exception of submissions identifying possible errors in data or data analysis or by appeal to the Editor. The letters will be edited for clarity and length. Readers wishing to submit a letter should access the article and click on "Letters: Submit a Response" in the box on the right-hand side of the opening page. Letters are not indexed by PubMed.

Authors of letters sent to Neurology: Neuroimmunology & Neuroinflammation should keep the following statement from the Uniform Requirements for Medical Journal Editors in mind:

"Although editors have the prerogative to sift out correspondence material that is irrelevant, uninteresting, or lacking in cogency, they have a responsibility to allow a range of opinion to be expressed. The correspondence column should not be used merely to promote the Journal's or the editors' point of view. In all instances, editors must make an effort to screen out discourteous, inaccurate, or libelous statements, and should not allow ad hominem arguments intended to discredit opinions or findings."

• Maximum of 200 words
• Maximum of 5 references; reference 1 must be the article on which you are commenting
• Maximum of 5 authors (replies can incorporate full original article author list)